Publications by authors named "Eric Jourdan"

Claim this Profile
E
Exploring the impact of solar radiation on skin microbiome to develop improved photoprotection strategies.
Yolanda Gilaberte, Jaime Piquero-Casals, Sergio Schalka, Giovanni Leone, Anthony Brown, Eric Jourdan

Photochem Photobiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Supplementation with l-Cystine, , , and in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study.
Jaime Piquero-Casals, David Saceda-Corralo, Sonia Aladren, Javier Bustos, Alfonso Fernández-Botello, Eric Jourdan

Skin Appendage Disord· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective requesting method to detect fusion transcripts in chronic myelomonocytic leukemia RNA-seq.
Florence Rufflé, Jérôme Reboul, Anthony Boureux, Benoit Guibert, Chloé Bessière, Eric Jourdan

NAR Genom Bioinform· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of a depigmenting gel serum comprising tranexamic acid, niacinamide, 4-butylresorcinol, phytic acid, and a mixture of hydroxy acids that targets the biological processes regulating skin melanogenesis.
Marta Furmanczyk, Anthony Brown, Javier Bustos, Antonio R Fernández de Henestrosa, Carles Trullas, Eric Jourdan

J Cosmet Dermatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposome Impact on Nail Health.
Ludmila Prudkin, Stephano Cedirian, Júlia Santamaria, Eric Jourdan, Bianca Maria Piraccini

Skin Appendage Disord· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study.
Ludovic Gabellier, Pierre Peterlin, Sylvain Thepot, Yosr Hicheri, Franciane Paul, Eric Jourdan

Ann Hematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the factors influencing sun protection factors (SPF): Pooling data from multiple studies involving two reference ISO 24444:2019 sunscreen products (P2 and P8).
Corinne Granger, Carles Trullàs, Nusayha Bibi Sokeechand, Eric Jourdan, Jean Krutmann

Photodermatol Photoimmunol Photomed· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.
Corentin Orvain, Sylvain Chantepie, Xavier Thomas, Martine Escofrre-Barbe, Francoise Huguet, Eric Jourdan

Haematologica· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural Retinol Analogs Potentiate the Effects of Retinal on Aged and Photodamaged Skin: Results from In Vitro to Clinical Studies.
Anthony Brown, Marta Furmanczyk, David Ramos, Adrià Ribes, Laia Pons, Eric Jourdan

Dermatol Ther (Heidelb)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice.
Shanti Amé, Fiorenza Barraco, Jean-Christophe Ianotto, Eric Jourdan, Jérôme Rey

EJHaem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO.
Pierre-Yves Dumas, Emmanuel Raffoux, Emilie Bérard, Sarah Bertoli, Marie-Anne Hospital, Eric Jourdan

Leukemia· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Rinse Solutions on (Cnidaria: Scyphozoa) Stings and the Ineffective Role of Vinegar in Scyphozoan Jellyfish Species.
Ainara Ballesteros, Macarena Marambio, Carles Trullas, Eric Jourdan, Jose Tena-Medialdea

Int J Environ Res Public Health· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substantivity of mouth-rinse formulations containing cetylpyridinium chloride and O-cymen-5-ol: a randomized-crossover trial.
Felipe-Rodrigo Aguilera, Miguel Viñas, Josep M Sierra, Teresa Vinuesa, Antonio R Fernandez de Henestrosa, Eric Jourdan

BMC Oral Health· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and clinical outcomes of SARS-CoV-2 infection in adult patients with acute leukemia in France.
Pierre-Yves Dumas, Sarah Bertoli, Caroline Bonmati, Martin Carre, Juliette Lambert, Eric Jourdan

Leuk Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis.
Claire N Harrison, Vikas K Gupta, Aaron T Gerds, Raajit Rampal, Srdan Verstovsek, Eric Jourdan

Future Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Nematocyst Discharge from (Cnidaria: Scyphozoa)-Prevention Measures against Jellyfish Stings.
Ainara Ballesteros, Carles Trullas, Eric Jourdan, Josep-Maria Gili

Mar Drugs· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial Assay for Safe First-Aid Protocol for the Stinging Sea Anemone (Cnidaria: Anthozoa) and a Severe Toxic Reaction.
Ainara Ballesteros, Janire Salazar, Macarena Marambio, José Tena, José Rafael García-March, Eric Jourdan

Toxins (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated results of the placebo-controlled, phase III JAKARTA trial of fedratinib in patients with intermediate-2 or high-risk myelofibrosis.
Animesh Pardanani, Ayalew Tefferi, Tamás Masszi, Elena Mishchenko, Mark Drummond, Eric Jourdan

Br J Haematol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial.
Francois Guilhot, Françoise Rigal-Huguet, Joëlle Guilhot, Agnès-Paule Guerci-Bresler, Frédéric Maloisel, Eric Jourdan

Leukemia· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial.
Anne Bouvier, Jean-François Hamel, Jacques Delaunay, Eric Delabesse, Pierre-Yves Dumas, Eric Jourdan

Eur J Haematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional status.
Claire Jouzier, Jean-François Hamel, Pierre-Yves Dumas, Jacques Delaunay, Caroline Bonmati, Eric Jourdan

Eur J Haematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study.
Laetitia Largeaud, Pascale Cornillet-Lefebvre, Jean-François Hamel, Pierre-Yves Dumas, Naïs Prade, Eric Jourdan

Leukemia· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial.
Claire N Harrison, Nicolaas Schaap, Alessandro M Vannucchi, Jean-Jacques Kiladjian, Eric Jourdan

Hemasphere· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure.
Claire N Harrison, Nicolaas Schaap, Alessandro M Vannucchi, Jean-Jacques Kiladjian, Eric Jourdan

Am J Hematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Occupational Pesticide Exposure With Immunochemotherapy Response and Survival Among Patients With Diffuse Large B-Cell Lymphoma.
Sylvain Lamure, Camille Carles, Quam Aquereburu, Philippe Quittet, Emmanuelle Tchernonog, Eric Jourdan

JAMA Netw Open· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis